This world-class eye care facility has been built at an investment of around Rs 75 crore. With this expansion, Sankara Eye Hospital, Pedakakani, Guntur, aims to double its annual free eye surgeries from 30,000 to 60,000 for economically weaker sections. The new facility, built
Second quarter revenue from operations grows 4% sequentially and 2% year-on-year to Rs. 911 Cr 1st half revenue from operations up 6% Syngene International Limited today announced financial results for the second quarter and half year of FY26. Quarterly Financial Highlights (All numbers are in Indian Rupees in Cr except margins) Q2 FY25Q2 FY26YoY Change (%)Revenue from Operations8919112%Reported Revenue9089262%Reported EBITDA261215-18%Reported EBITDA margin (%)28.8%23.2% Reported PAT (before exceptional items)10667-37%Reported PAT Margin (%)11.7%7.3% H1 FY26 Financial Highlights (All numbers are in Indian rupees in Crores except margins) H1 FY25H1 FY26YoY Change (%)Revenue from Operations1,6811,7856%Reported Revenue1,7151,8186%Reported EBITDA449439-2%Reported EBITDA margin (%)26.2%24.1% Reported PAT (before exceptional items)161*154-4%Reported PAT Margin (%)9.4%8.5% Excludes exceptional item of Rs. 21 crores (net of tax) in Q1 FY25 relating to final settlement from an insurance claim. Commenting on the results, Peter Bains, Managing Director and CEO, Syngene International Limited, said, “Our Q2 performance was driven by underlying revenue growth from research
The approvals strengthen India’s position as a reliable supplier of advanced pharmaceuticals across ASEAN markets where Venus Remedies already exports more than 374 products. Venus Remedies Limited (NSE: VENUSREM, BSE: 526953), among the 10 leading fixed-dosage injectable manufacturers in the world, has secured new marketing authorizations
Commits ₹125 crore investment to develop its first 100-bed integrative AYUSH hospital in Bengaluru SOUKYA International Holistic Health Centre, globally acclaimed for its premium holistic therapies, has acquired six acres of land near its existing campus in Hoskote, Bengaluru, as part of its plans to establish
Kolkata, 8th November, 2025: With the world celebrating World Radiography Day on November 8th, 2025, honoring the anniversary of Wilhelm Conrad Röntgen’s discovery of X-Rays in the year 1895, a breakthrough in revolutionising medical diagnosis and treatment, Suraksha Diagnostic Limited (“Suraksha Clinic and Diagnostics), one
- New Centres of Excellence include Cardiac Sciences, Renal Sciences, Neurosciences, and Gastro Sciences; Oncology to follow - Expansion from 200 to over 600 beds planned over the next five years, with a focus on AI, robotics, and digital health. - Launch of a new logo that
National campaign urging Indians to embrace cancer screening before symptoms appearNovember 6, 2015, Mumbai: The third edition of Sanjeevani: United Against Cancer - a transformative initiative by Federal Bank Hormis Memorial Foundation, News18 Network, and knowledge partner Tata Trusts—launches today with a clarion call: early
In view of the alarming rise of cancer cases across the country and to make advanced, integrated oncology care accessible in Southern India, SPARSH Group of Hospitals inaugurated the SPARSH Institute of Cancer Care at its 300-bed quaternary care facility on Hennur Road, Bengaluru.The new
Warns of further 15–20% inflation in the coming year, putting even greater pressure on underinsured Indian householdsBengaluru, India | November 5, 2025: Plum, India’s leading employee health benefits platform, today unveiled the latest findings from its proprietary insights engine – Plum Data Labs – spotlighting
6th November 2025: Medanta – The Medicity, one of India’s leading super-speciality hospitals, ranked the Best Private Hospital in India by Newsweek for six consecutive years, has announced the launch of its Advanced Surgical Heart Failure Clinic, a specialized centre dedicated to the diagnosis, surgical
